{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:30:24Z","timestamp":1792009824443,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012964","name":"Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004409","name":"Ministry of Higher Education and Scientific Research","doi-asserted-by":"publisher","award":["LR99ES11"],"award-info":[{"award-number":["LR99ES11"]}],"id":[{"id":"10.13039\/501100004409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.plefa.2024.102628","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T16:29:10Z","timestamp":1719851350000},"page":"102628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Abnormal expression of oxylipins and related synthesizing\/signaling pathways in inflammatory bowel diseases"],"prefix":"10.1016","volume":"202","author":[{"given":"Yamina","family":"Ben-Mustapha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Rekik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Ben-Fradj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Serghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Sanhaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Ben-Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalel","family":"Boubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1585-4052","authenticated-orcid":false,"given":"Moncef","family":"Feki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2024.102628_bib0001","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/MCG.0000000000000660","article-title":"World gastroenterology organisation global guidelines inflammatory bowel disease: update August 2015","volume":"50","author":"Bernstein","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.plefa.2024.102628_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7247238","article-title":"Comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Q. Guan","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.plefa.2024.102628_bib0003","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not","volume":"177","author":"Serhan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plefa.2024.102628_bib0004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molmed.2018.12.004","article-title":"Saving problematic mucosae: SPMs in intestinal mucosal inflammation and repair","volume":"25","author":"Quiros","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.plefa.2024.102628_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prostaglandins.2015.04.001","article-title":"Impact of colonic mucosal lipoxin A4 synthesis capacity on healing in rats with dextran sodium sulfate-induced colitis","volume":"121","author":"A\u011f\u0131\u015f","year":"2015","journal-title":"Prostaglandins Other Lipid. Mediat."},{"key":"10.1016\/j.plefa.2024.102628_bib0006","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/gutjnl-2014-306998","article-title":"Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis","volume":"64","author":"Masterson","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.plefa.2024.102628_bib0007","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1073\/pnas.1617290114","article-title":"Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection","volume":"114","author":"Gobbetti","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.plefa.2024.102628_bib0008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00365529509093234","article-title":"Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease","volume":"30","author":"Ikehata","year":"1995","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.plefa.2024.102628_bib0009","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ibd.20094","article-title":"Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases","volume":"13","author":"Jupp","year":"2007","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1515\/hsz-2016-0200","article-title":"Annexin A1 and resolution of inflammation: tissue repairing properties and signaling signature","volume":"397","author":"Gobbetti","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.plefa.2024.102628_bib0011","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ibd\/izy349","article-title":"A quantitative analysis of colonic mucosal oxylipins and endocannabinoids in treatment-na\u00efve and deep remission ulcerative colitis patients and the potential link with cytokine gene expression","volume":"25","author":"Diab","year":"2019","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0012","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/jcm11071861","article-title":"Involvement of proinflammatory arachidonic acid (ARA) derivatives in Crohn's disease (CD) and ulcerative colitis (UC)","volume":"11","author":"Kikut","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.plefa.2024.102628_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714138","article-title":"Formyl peptide receptors and annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease","volume":"12","author":"de Paula-Silva","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2024.102628_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106741","article-title":"Altered mucosal and plasma polyunsaturated fatty acids, oxylipins, and endocannabinoids profiles in Crohn's disease","volume":"168","author":"Ben-Mustapha","year":"2023","journal-title":"Prostaglandins Other Lipid. Mediat."},{"key":"10.1016\/j.plefa.2024.102628_bib0015","doi-asserted-by":"crossref","first-page":"89581","DOI":"10.1155\/MI\/2006\/89581","article-title":"Regulated spatial distribution of cyclooxygenases and lipoxygenases in Crohn's ulcer","volume":"2006","author":"Mao","year":"2006","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.plefa.2024.102628_bib0016","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/ajpgi.00042.2011","article-title":"Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production","volume":"301","author":"Prescott","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.plefa.2024.102628_bib0017","doi-asserted-by":"crossref","first-page":"e39244","DOI":"10.1371\/journal.pone.0039244","article-title":"Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis","author":"Vong","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.plefa.2024.102628_bib0018","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2015.05.015","article-title":"A comprehensive quantification method for eicosanoids and related compounds using liquid chromatography\/mass spectrometry with high-speed continuous ionization polarity switching","volume":"995-996","author":"Yamada","year":"2015","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.plefa.2024.102628_bib0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02762340","article-title":"Reverse transcriptase. The use of cloned Moloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA","volume":"8","author":"Gerard","year":"1997","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.plefa.2024.102628_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.athoracsur.2004.09.040","article-title":"Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests","volume":"79","author":"Jones","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.plefa.2024.102628_bib0021","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ibd\/izad080","article-title":"A novel serum metabolomic panel for the diagnosis of Crohn's disease","volume":"29","author":"Ma","year":"2023","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ibd\/izad154","article-title":"Serum and urine metabolomic profiling of newly diagnosed treatment-na\u00efve inflammatory bowel disease patients","volume":"30","author":"Aldars-Garc\u00eda","year":"2024","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0023","doi-asserted-by":"crossref","first-page":"e76532","DOI":"10.1371\/journal.pone.0076532","article-title":"Altered colonic mucosal polyunsaturated fatty acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology","volume":"8","author":"Masoodi","year":"2013","journal-title":"PloS One."},{"key":"10.1016\/j.plefa.2024.102628_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.crohns.2013.03.013","article-title":"Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity","volume":"8","author":"Pearl","year":"2014","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.plefa.2024.102628_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","article-title":"Alterations in lipid, amino acid, and energy metabolism distinguish Crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling","volume":"14","author":"Scoville","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.plefa.2024.102628_bib0026","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/foods10010199","article-title":"Omega-3 polyunsaturated fatty acids and the intestinal epithelium-a review","volume":"10","author":"Durkin","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.plefa.2024.102628_bib0027","article-title":"Nutritional lipids and mucosal inflammation","volume":"65","author":"Wawrzyniak","year":"2021","journal-title":"Mol. Nutr. Food. Res."},{"key":"10.1016\/j.plefa.2024.102628_bib0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.prostaglandins.2005.10.004","article-title":"Lipoxin biosynthesis in inflammatory bowel disease","volume":"79","author":"Mangino","year":"2006","journal-title":"Prostaglandins Other Lipid. Mediat."},{"key":"10.1016\/j.plefa.2024.102628_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113167","article-title":"Recent advances in the design and development of formyl peptide receptor 2 (FPR2\/ALX) agonists as pro-resolving agents with diverse therapeutic potential","volume":"213","author":"Maciuszek","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.plefa.2024.102628_bib0030","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1038\/emm.2013.77","article-title":"The immune-stimulating peptide WKYMVM has therapeutic effects against ulcerative colitis","volume":"45","author":"Kim","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.plefa.2024.102628_bib0031","doi-asserted-by":"crossref","first-page":"13632","DOI":"10.1096\/fj.201901163R","article-title":"Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair","volume":"33","author":"Birkl","year":"2019","journal-title":"FASEB. J."},{"key":"10.1016\/j.plefa.2024.102628_bib0032","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000505910","article-title":"Annexin A1 expression capacity as a determinant for disease severity in Crohn's Disease","volume":"38","author":"Reischl","year":"2020","journal-title":"Dig. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0033","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00054725-200409000-00013","article-title":"Annexin 1 is secreted in situ during ulcerative colitis in humans","volume":"10","author":"Vergnolle","year":"2004","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0034","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2015.08.050","article-title":"EPA- and DHA-derived resolvins' actions in inflammatory bowel disease","volume":"785","author":"Schwanke","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.plefa.2024.102628_bib0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"K\u00fchn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.plefa.2024.102628_bib0036","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plefa.2024.102628_bib0037","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fimmu.2020.01315","article-title":"IL-10 and IL-22 in mucosal immunity: driving protection and pathology","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2024.102628_bib0038","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00054725-200606000-00003","article-title":"Functional CD4+CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity","volume":"12","author":"Holm\u00e9n","year":"2006","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.plefa.2024.102628_bib0039","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.plefa.2024.102628_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2005.07.181","article-title":"The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids","volume":"338","author":"Arita","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2024.102628_bib0041","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232782400022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232782400022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:37:53Z","timestamp":1726101473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232782400022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"alternative-id":["S095232782400022X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2024.102628","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal expression of oxylipins and related synthesizing\/signaling pathways in inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2024.102628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102628"}}